Parsaclisib in Japanese patients with relapsed or refractory B‐cell lymphoma (CITADEL‐111): A phase Ib study-Reference-Cited by-同舟云学术

Parsaclisib in Japanese patients with relapsed or refractory B‐cell lymphoma (CITADEL‐111): A phase Ib study

Published:2022-03-15 Issue:5 Volume:113 Page:1702-1711
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Science

Author:

Fukuhara Noriko¹,Suehiro Youko²,Kato Harumi³,Kusumoto Shigeru⁴^ORCID,Coronado Cinthya⁵,Rappold Erica⁵,Zhao Wanying⁵,Li Jia⁵,Gilmartin Aidan⁵,Izutsu Koji⁶^ORCID

Affiliation:

1. Department of Hematology Tohoku University Hospital Sendai Japan

2. Department of Hematology National Hospital Organization Kyushu Cancer Center Fukuoka Japan

3. Department of Hematology and Cell Therapy Aichi Cancer Center Hospital Nagoya Japan

4. Department of Hematology and Oncology Nagoya City University Graduate School of Medical Sciences Nagoya Japan

5. Incyte Corporation Wilmington Delaware USA

6. Department of Hematology National Cancer Center Hospital Tokyo Japan

Funder

Incyte

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.15308

Reference25 articles.

1. Non-Hodgkin lymphoma

2. Targeting B-cell receptor signaling in leukemia and lymphoma: how and why?

3. Targeting the B cell receptor pathway in non-Hodgkin lymphoma

4. Mechanisms of B Cell Receptor Activation and Responses to B Cell Receptor Inhibitors in B Cell Malignancies

5. Targeting of B-cell receptor signalling in B-cell malignancies

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted Inhibition of the PI3K/Akt/mTOR Signaling Axis: Potential for Sarcoma Therapy;Mini-Reviews in Medicinal Chemistry;2024-09

2. Targeted small molecule therapy and inhibitors for lymphoma;Future Medicinal Chemistry;2024-07-17

3. Recent advances in treatment of follicular lymphoma: efficacy of PI3Kα/δ inhibitor (TQ-B3525);Signal Transduction and Targeted Therapy;2024-05-16

4. Gene targeted and immune therapies for nodal and gastrointestinal follicular lymphomas;World Journal of Gastroenterology;2023-12-28

5. Small molecule inhibitors targeting regulatory T cells for cancer treatment;European Journal of Immunology;2023-11-15